|
Section 708A(5)(e) Notice
|
27 June 2023 at 7:35pm
|
|
Application for quotation of securities - BOT
|
27 June 2023 at 7:35pm
|
|
Section 708A(5)(e) Notice
|
15 June 2023 at 2:35pm
|
|
Application for quotation of securities - BOT
|
15 June 2023 at 2:35pm
|
|
Investor Webinar Presentation
|
7 June 2023 at 11:20am
|
|
New Territory Licensed for Sofpironium Bromide with Kaken
|
5 June 2023 at 12:10pm
|
|
Pause in trading
|
5 June 2023 at 10:20am
|
|
Botanix Investor Webinar
|
2 June 2023 at 10:59am
|
|
Change of Director's Interest Notice x 3
|
22 May 2023 at 7:40pm
|
|
Notification of cessation of securities - BOT
|
22 May 2023 at 7:35pm
|
|
Appendix 2A and Section 708A(5)(e) Notice - amended
|
22 May 2023 at 7:35pm
|
|
Notice Under Section 708A(5)(e) of the Corporations Act
|
18 May 2023 at 7:45pm
|
|
Application for quotation of securities - BOT
|
18 May 2023 at 7:40pm
|
|
March 2023 Quarterly Activities Report and Appendix 4C
|
28 April 2023 at 2:20pm
|
|
Change in substantial holding from IFL
|
18 April 2023 at 5:05pm
|
|
Company Secretary Change
|
17 April 2023 at 8:50am
|
|
Botanix successfully completes A$10m Placement Revised
|
13 April 2023 at 12:45pm
|
|
Botanix successfully completes A$10m Placement
|
13 April 2023 at 9:55am
|
|
Notice under Section 708A(5)(e) of the Corporations Act
|
13 April 2023 at 9:55am
|
|
Application for quotation of securities - BOT
|
13 April 2023 at 9:50am
|
|
Application for quotation of securities - BOT
|
13 April 2023 at 9:50am
|
|
Investor Update
|
5 April 2023 at 10:15am
|
|
Proposed issue of securities - BOT
|
5 April 2023 at 10:15am
|
|
Botanix Raises A$10 million via Institutional Placement
|
5 April 2023 at 10:15am
|
|
Trading Halt
|
3 April 2023 at 9:55am
|
|
FDA Mid-Cycle Review Meeting Successfully Completed
|
3 April 2023 at 9:10am
|
|
Change of Director's Interest Notice * 5
|
20 March 2023 at 6:30pm
|
|
Notice under Section 708A(5)(e) of the Corporations Act
|
20 March 2023 at 6:30pm
|
|
Application for quotation of securities - BOT
|
20 March 2023 at 6:20pm
|
|
Application for quotation of securities - BOT
|
20 March 2023 at 5:55pm
|
|
Notification regarding unquoted securities - BOT
|
14 March 2023 at 7:50pm
|
|
Response to ASX Price and Volume Query
|
10 March 2023 at 7:15pm
|
|
Webinar Updated Commercial Research for Sofpironium Bromide
|
9 March 2023 at 10:30am
|
|
Botanix To Host Investor Webinar
|
8 March 2023 at 3:25pm
|
|
Half Yearly Report and Accounts
|
28 February 2023 at 5:05pm
|
|
Press Article Correction
|
15 February 2023 at 10:05am
|
|
Trading Halt
|
14 February 2023 at 11:50am
|
|
Pause in Trading
|
14 February 2023 at 10:20am
|
|
Investor Presentation and Video
|
31 January 2023 at 10:05am
|
|
Appendix 4C - Quarterly
|
31 January 2023 at 9:45am
|
|
Botanix attends JP Morgan Healthcare Conference
|
9 January 2023 at 9:55am
|
|
Change of Director's Interest Notice * 5
|
4 January 2023 at 10:30am
|
|
Notification regarding unquoted securities - BOT
|
4 January 2023 at 10:20am
|
|
Change of Director's Interest Notice *5
|
14 December 2022 at 7:10pm
|
|
Notice under Section 708A(5)(e) of the Corporations Act
|
12 December 2022 at 3:20pm
|
|
Application for quotation of securities - BOT
|
12 December 2022 at 3:10pm
|
|
Notification regarding unquoted securities - BOT
|
12 December 2022 at 3:00pm
|
|
Confirmation Sofpironium Bromide NDA Formally Under Review
|
8 December 2022 at 10:05am
|
|
Application for quotation of securities - BOT
|
30 November 2022 at 12:20pm
|
|
Notice Under Section 708A(5)(e) of the Corporations Act 2001
|
29 November 2022 at 9:45am
|
Botanix Pharmaceuticals